Droplet digital polymerase chain reaction assay for screening of ESR1 mutations in 325 breast cancer specimens

Translational Research

Volumn 166, Issue 6, 2015, Pages 540-553.e2

  Takeshita, Takashi ^a   Yamamoto, Yutaka ^b   Yamamoto Ibusuki, Mutsuko ^a   Inao, Toko ^a   Sueta, Aiko ^b   Fujiwara, Saori ^a   Omoto, Yoko ^a,c   Iwase, Hirotaka ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA, HUMAN;

ADULT; AGED; ARTICLE; ASSAY; BREAST BIOPSY; BREAST CANCER; BREAST METASTASIS; CONTROLLED STUDY; DROPLET DIGITAL POLYMERASE CHAIN REACTION; FEMALE; GENE MUTATION; GENETIC SCREENING; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOLECULE; MUTANT; NEXT GENERATION SEQUENCING; POLYMERASE CHAIN REACTION; PRIMARY TUMOR; PRIORITY JOURNAL; BREAST TUMOR; GENETICS; METASTASIS; MIDDLE AGED; MUTATION; PATHOLOGY; PROCEDURES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; MIDDLE AGED; MUTATION; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION;

EID: 84960490504     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2015.09.003     Document Type: Article

References (30)

1. H. Iwase Current topics and perspectives on the use of aromatase inhibitors in the treatment of breast cancer Breast Cancer 15 2008 278 290
2. M. Baum, A.U. Budzar, J. Cuzick, and et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: First results of the ATAC randomised trial Lancet 359 2002 2131 2139
3. V.C. Jordan, R. Curpan, and P.Y. Maximov Estrogen receptor mutations found in breast cancer metastases integrated with the molecular pharmacology of selective ER modulators J Natl Cancer Inst 107 2015 10.1093/jnci/djv075
4. S.A. Fuqua, S.D. Fitzgerald, D.C. Allred, and et al. Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors Cancer Res 52 1992 483 486
5. K.E. Weis, K. Ekena, J.A. Thomas, G. Lazennec, and B.S. Katzenellenbogen Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein Mol Endocrinol 10 1996 1388 1398
6. S. Li, D. Shen, J. Shao, and et al. Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts Cell Rep 4 2013 1116 1130
7. D.R. Robinson, Y.M. Wu, P. Vats, and et al. Activating ESR1 mutations in hormone-resistant metastatic breast cancer Nat Genet 45 2013 1446 1451
8. W. Toy, Y. Shen, H. Won, and et al. ESR1 ligand-binding domain mutations in hormone-resistant breast cancer Nat Genet 45 2013 1439 1445
9. R. Jeselsohn, R. Yelensky, G. Buchwalter, and et al. Emergence of constitutively active estrogen receptor-alpha mutations in pretreated advanced estrogen receptor-positive breast cancer Clin Cancer Res 20 2014 1757 1767
10. S.J. Dawson, D.W. Tsui, M. Murtaza, and et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer N Engl J Med 368 2013 1199 1209
11. C.M. Hindson, J.R. Chevillet, H.A. Briggs, and et al. Absolute quantification by droplet digital PCR versus analog real-time PCR Nat Methods 10 2013 1003 1005
12. B. Vogelstein, and K.W. Kinzler Digital PCR Proc Natl Acad Sci US A 96 1999 9236 9241
13. Y.M. Lo, F.M. Lun, K.C. Chan, and et al. Digital PCR for the molecular detection of fetal chromosomal aneuploidy Proc Natl Acad Sci USA 104 2007 13116 13121
14. B.J. Hindson, K.D. Ness, D.A. Masquelier, and et al. High-throughput droplet digital PCR system for absolute quantitation of DNA copy number Anal Chem 83 2011 8604 8610
15. L.B. Pinheiro, V.A. Coleman, C.M. Hindson, and et al. Evaluation of a droplet digital polymerase chain reaction format for DNA copy number quantification Anal Chem 84 2012 1003 1011
16. A. Goldhirsch, W.C. Wood, R.D. Gelber, and et al. Meeting highlights: Updated international expert consensus on the primary therapy of early breast cancer J Clin Oncol 21 2003 3357 3365
17. A. Goldhirsch, J.H. Glick, R.D. Gelber, and et al. Meeting highlights: International expert consensus on the primary therapy of early breast cancer 2005 Ann Oncol 16 2005 1569 1583
18. A. Goldhirsch, W.C. Wood, R.D. Gelber, and et al. Progress and promise: Highlights of the international expert consensus on the primary therapy of early breast cancer 2007 Ann Oncol 18 2007 1133 1144
19. W.J. Gradishar, B.O. Anderson, S.L. Blair, and et al. Breast cancer version 3.2014 J Natl Compr Canc Netw 12 2014 542 590
20. T. Takeshita, Y. Omoto, M. Yamamoto-Ibusuki, Y. Yamamoto, and H. Iwase Clinical significance of androgen receptor and its phosphorylated form in breast cancer Endocr Relat Cancer 20 2013 L15 21
21. L.M. McShane, D.G. Altman, W. Sauerbrei, and et al. Reporting recommendations for tumor marker prognostic studies J Clin Oncol 23 2005 9067 9072
22. D.W. Bell, T.J. Lynch, S.M. Haserlat, and et al. Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: Molecular analysis of the IDEAL/INTACT gefitinib trials J Clin Oncol 23 2005 8081 8092
23. X. Fan, F.B. Furnari, W.K. Cavenee, and J.S. Castresana Non-isotopic silver-stained SSCP is more sensitive than automated direct sequencing for the detection of PTEN mutations in a mixture of DNA extracted from normal and tumor cells Int J Oncol 18 2001 1023 1026
24. D. Sefrioui, A. Perdrix, N. Sarafan-Vasseur, and et al. Short report: Monitoring ESR1 mutations by circulating tumor DNA in aromatase inhibitor resistant metastatic breast cancer Int J Cancer 137 2015 2513 2519
25. M.J. Ellis, L. Ding, D. Shen, and et al. Whole-genome analysis informs breast cancer response to aromatase inhibition Nature 486 2012 353 360
26. P.J. Stephens, P.S. Tarpey, H. Davies, and et al. The landscape of cancer genes and mutational processes in breast cancer Nature 486 2012 400 404
27. S. Banerji, K. Cibulskis, C. Rangel-Escareno, and et al. Sequence analysis of mutations and translocations across breast cancer subtypes Nature 486 2012 405 409
28. H. Iwase, Y. Yamamoto, M. Yamamoto-Ibusuki, and et al. Ethinylestradiol is beneficial for postmenopausal patients with heavily pre-treated metastatic breast cancer after prior aromatase inhibitor treatment: A prospective study Br J Cancer 109 2013 1537 1542
29. Y. Omoto, T. Takeshita, Y. Yamamoto, and et al. Immunohistochemical analysis in ethinylestradiol-treated breast cancers after prior long-term estrogen-deprivation therapy Springerplus 4 2015 108
30. M.J. Ellis, F. Gao, F. Dehdashti, and et al. Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: A phase 2 randomized study JAMA 302 2009 774 780